Replies to post #3 on Collabrx, Inc. (CLRX)

[Gulo]

I think you might be right, but I think it would be a double or triple at most. CLRX has enough cash to last the year and may not be cash-flow positive when that happens. Foundation has the backing of major venture caps. If it were a head-to-head race, it would not be a contest. Maybe CLRX can find a niche provding the software to the rest of the personal medicine market outside of Foundation.